Can the municipalities prevent medication of lifestyle related diseases?

In extension of a large municipality reform in 2007, which reduced the number of Danish municipalities from 275 to 98, it was the intention that the municipalities should assume responsibility for a part of the expenditure connected to secondary sector health care treatment. Furthermore, the municip...

Full description

Bibliographic Details
Main Authors: Mickael Bech, Maja Bæksgaard Hansen, Jørgen Lauridsen, Christian Kronborg
Format: Article
Language:English
Published: University of Oslo 2012-07-01
Series:Nordic Journal of Health Economics
Subjects:
Online Access:https://journals.uio.no/NJHE/article/view/204
Description
Summary:In extension of a large municipality reform in 2007, which reduced the number of Danish municipalities from 275 to 98, it was the intention that the municipalities should assume responsibility for a part of the expenditure connected to secondary sector health care treatment. Furthermore, the municipalities were assigned the responsibility for – and equipped with a number of opportunities for – exerting primary preventive initiatives. The purpose of the present study is to investigate, whether the municipalities by applying these opportunities have been able to prevent medication of selected lifestyle related diseases (type 2 diabetes, cardiovascular diseases, and asthma and chronically obstructive lung disease). Though our results initially seem to support this, a closer investigation indicates that the relationship between municipal preventive initiatives and medication is a structural, intra-municipal relationship rather than a cause-response effect.
ISSN:1892-9729
1892-9710